🔎 Trials Near Me

Home › Myotonic Dystrophy › New York › Rochester

Myotonic Dystrophy clinical trials in Rochester, NY

7 studies for Myotonic Dystrophy are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

RecruitingPhase 3
  • University of Rochester Medical Center, Rochester
Ages 16 and older · All sexes · Updated Sep 25, 2026 · NCT07486934

Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)

RecruitingObservational study
  • University of Rochester, Rochester
Ages 18 to 70 · All sexes · Updated Jun 10, 2026 · NCT03981575

DMCRN-02-001: Assessing Pediatric Endpoints in DM1

RecruitingObservational study
  • University of Rochester Medical Center, Rochester
59 Months · All sexes · Updated Jun 10, 2026 · NCT05224778

Remote Assessments and Genetic Determinants of Congenital and Childhood Myotonic Dystrophy

RecruitingObservational study
  • University of Rochester, Rochester
Ages 0 to 17 · All sexes · Updated Jun 5, 2026 · NCT07630389

Remote Assessments and Genetic Determinants of Myotonic Dystrophy

RecruitingObservational study
  • University of Rochester, Rochester
Ages 18 to 88 · All sexes · Updated Apr 1, 2026 · NCT07505342

Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry

RecruitingObservational studyHealthy volunteers welcome
  • University of Rochester Medical Center, Department of Neurology, Rochester
All ages · All sexes · Updated Oct 15, 2025 · NCT00082108

Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy

RecruitingPhase 2/3
  • University of Rochester - Medical Center, Rochester
Ages 6 to 45 · All sexes · Updated May 28, 2025 · NCT05004129

Myotonic Dystrophy trials in other cities

Other studies in Rochester

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.